J Biol Chem, Vol. 274, Issue 45, 32287-32294, November 5, 1999
An Atypical Form of
B-crystallin Is Present in High
Concentration in Some Human Cataractous Lenses
IDENTIFICATION AND CHARACTERIZATION OF ABERRANT N- AND
C-TERMINAL PROCESSING*
Jose
Jimenez-Asensio
,
Christine M.
Colvis
,
Jeffrey A.
Kowalak§,
Yvonne
Duglas-Tabor,
Manuel B.
Datiles,
Maria
Moroni,
Umberto
Mura¶,
Ch. Mohan
Rao
,
Dorairajan
Balasubramanian**,
Alireza
Janjani
, and
Donita
Garland§§
From the NEI and the § NICHHD, National Institutes of
Health, Bethesda, Maryland 20892, the ¶ University of Pisa,
56100 Pisa, Italy, the
Center for Cellular and Molecular
Biology, 500 007 Hyderabad, India, and the ** L.V. Prasad Eye
Institute, 500 034 Hyderabad, India
 |
ABSTRACT |
Two unique polypeptides, 22.4 and 16.4 kDa, were
prominent in some human cataracts. Both proteins were identified as
modified forms of the small heat shock protein,
B-crystallin. The
concentration of total
B-crystallin in most of these cataracts was
significantly increased. The 22.4-kDa protein was subsequently
designated as
Bg. Mass spectrometric analyses of
tryptic and Asp-N digests showed
Bg is
B-crystallin
minus the C-terminal lysine.
Bg constituted 10-90% of
the total
B-crystallin in these cataracts and was preferentially phosphorylated over the typical form of
B-crystallin. Human
Bg and
B-crystallin were cloned and expressed in
Escherichia coli. The differences in electrophoretic
mobility and the large difference in native pI values suggest some
structural differences exist. The chaperone-like activity of
recombinant human
Bg was comparable to that of
recombinant human
B-crystallin in preventing the aggregation of
lactalbumin induced by dithiothreitol. The mechanism involved in
generating
Bg is not known, but a premature termination
of the
B-crystallin gene was ruled out by sequencing the polymerase chain reaction products of the last exon for the
B-crystallin gene
from lenses containing
Bg. The 16.4-kDa protein was an
N-terminally truncated fragment of
Bg. The high
concentration of
B-crystallin in these cataracts is the first
observation of this kind in human lenses.
 |
INTRODUCTION |
The three major classes of mammalian crystallins,
-,
-, and
-crystallins, constitute about 90% of the total protein in the eye
lens and are considered to determine the refractive properties of the
lens. Post-translational modification of the crystallins has been a
major focus of the research in trying to elucidate causes for the loss
of lens transparency or cataract development (1-4).
-Crystallins
have received the most attention in this case. The two homologous
subunits,
A- and
B-crystallin, make up about 30% of the proteins
in young human lenses and in the outer cortex of the adult human lens.
B-crystallin is a normal constituent of most mammalian tissues but
is present in the highest concentrations in lens (5, 6). In addition to
the lens,
A-crystallin is found in spleen and thymus (7).
-Crystallins are present in fiber cell extracts as large
heteroaggregates with apparent molecular masses reported from 300 to
1000 kDa (8, 9). In cataracts the sizes of the aggregates reportedly
increase and these aggregates are thought to be responsible for the
light scattering (2).
On the other hand,
-crystallins are members of the family of small
heat shock proteins and are thought to provide protection against
cellular stresses (10-12). Members of this family are structurally related via the
-crystallin domain, they form large aggregates, are
phospho-proteins, and have chaperone-like activity (12-19).
-
Crystallins prevent the aggregation of proteins induced by heat,
oxidation, or chemicals. In cultured cells, expression of
B-crystallin is induced by heat shock, oxidative stress, osmotic stress, arsenite, phorbol 12-myristate 13-acetate, and hormones such as
estrogen and dexamethasone (20-23). Thus, the role of
B-crystallin in many systems is considered to be that of a stress protein. In the
lens, however, it is not known whether the primary function of
B-crystallin is that of a stress protein and related to its chaperone-like function or if its major role is structural. It is
possible its role in the lens may change depending on the stage of
development and location in the lens.
Both
-crystallins undergo post-translational modifications including
truncation of both N and C termini, deamidation, racemization, phosphorylation, methionine oxidation, glycation, disulfide formation, addition of O-GlcNAc, and the addition of 72 mass units to
the C-terminal lysine of
B-crystallin (4, 17-19, 24, 25). Some of
these such as phosphorylation and specific cleavage may be important
functionally, others are likely the result of aging and detrimental
stresses. Any of these modifications are likely to alter the protein
conformation which in turn could alter the aggregate size and/or the
function of
- crystallin in the cell.
Two-dimensional electrophoresis of tissue proteins is the major
technique used to detect post-translationally modified proteins in cell
and tissue extracts. We have used this technique extensively in an
attempt to identify changes in the concentration or modification of
lens proteins that could be unique to developmental, aging, and
cataractogenic processes.
In this study we report the identification and characterization of two
unique polypeptides observed on two-dimensional gel electrophoresis of
human cataracts. One of the proteins was present in high concentration
comparable to the concentration of a crystallin. Both are likely the
result of stress-induced processes on the path to cataract formation.
 |
MATERIALS AND METHODS |
Normal Lenses and Cataracts--
Normal human lenses were
obtained from the National Disease Research Interchange, Philadelphia,
PA. Human cataractous material was obtained from intracapsular cataract
surgery done in India and from extracapsular extractions done at the
National Eye Institute. Tenets of the Declaration of Helsinki for
dealing with human samples were strictly followed. The lens capsule
epithelia were removed, and the lenses were separated into the lens
cortical and nuclear regions as described previously (26).
Two-dimensional Gel Electrophoresis--
A proteinase inhibitor
mixture containing 4-(2-aminoethyl)-benzenesulfonyl fluoride, pepstatin
A,
trans-epoxysuccinyl-L-leucylamido(4-guanidino)butane (E-64), bestatin, leupeptin, and aprotinin (Sigma) was added to frozen
lens cortex samples. The samples were thawed and homogenized in 9 M urea, 2 or 4% Nonidet P-40, 10 mM
DTT,1 2% Resolyte 3.5-10.
Two-dimensional gel electrophoresis was done according to previously
described procedures (27, 28). Non-linear, pH 3-10, 18-cm dry strips
(Amersham Pharmacia Biotech) were used. Samples were loaded onto the
acidic end and focused for 32,000 V-h. The strips were then frozen at
least 1 h and equilibrated twice, first in 50 mM Tris,
pH 6.8, containing 6 M urea, 1% SDS, with 1% DTT and then
in the same buffer mix but with 4.5% iodoacetamide. The second
dimension was done in the Iso-Dalt Gel Electrophoresis System using
15-18% gradient gels. Molecular weight markers (Bio-Rad) and pI
markers (carbamylated CPK, BDH Laboratory Supplies) were included.
Proteins were stained with colloidal Coomassie Blue G-250 or with
PhastGel BlueR (Amersham Pharmacia Biotech) when protein spots were
analyzed by mass spectrometry. Gels were scanned using a Molecular
Dynamics Personal Densitometer, and protein spots were quantified using
ImageQuant software.
Protein Sequencing and Immunoreactivity--
Proteins were
electrophoretically transferred from the two-dimensional gels to
polyvinylidene difluoride membranes (Millipore). Tryptic peptide maps
and Edman sequencing were done by Harvard MicroChem. Immunoreactivity
was determined using Tropix Western-Light detection kit (PE Applied BioSystems).
Mass Spectrometry--
Proteins were subjected to in-gel
digestion with either trypsin (Promega) or Asp-N endoproteinase (Wako)
as described previously (29). Extracted peptides were spotted with
-cyano-4-hydroxycinnamic acid and analyzed using a PE Biosystems
Voyager DE STR matrix-assisted laser desorption-time of flight
(MALDI-TOF) mass spectrometer. Data were processed using GRAMS/386 software.
Cloning of
B-crystallin and
Bg--
RNA was
obtained from a 16-year-old human lens. The isolation was done by
combining the guanidine isothiocyanate lysis with the silica gel
membrane technology using the Qiagen RNeasy kit. Oligo(dT)-primed
cDNA was prepared from total RNA using the Amersham Pharmacia
Biotech T-primed first strand kit. The coding regions of human
B-crystallin and
Bg were amplified by PCR using
primers containing NcoI or HindIII sites and were
inserted into the cloning vector pCR2.1-TOPO (Invitrogen, San Diego,
CA). In the PCR reactions the following primer (forward), which
corresponds to the 5' end of the coding region of human
B-crystallin, was used for both
B-crystallin and
Bg: 5'-TAAGAAGGAGATATACCATGGACATCGCCA-3'.
The reverse primers used for human
B-crystallin and
Bg were
5'-CAAAAGCTTATTACTATTTCTTGGGGGCTG-3' and
5'-GGCCGCAAGCTTTCACTTGGGGGCTG-3', respectively. The
latter will terminate the coding sequence after Lys174. The
underlined nucleotides indicate the restriction sites. The clones were
propagated in Escherichia coli DH5
TM (Life
Technologies Inc.). The coding region of these constructs were
confirmed by DNA sequence analysis using the dye terminator cycle
sequencing method (PE Applied Biosystems, Warrington, UK).
Construction of Expression Vectors--
The coding region of
human
B-crystallin and
Bg were removed from the
cloning vector by double digestion with NcoI and
HindIII restriction enzymes and ligated into
NcoI-HindIII-cut pET-21d(+) (Novagen, Madison,
WI). Recombinant plasmids were identified by NcoI-HindIII digestion and amplification of human
B-crystallin by PCR using internal primers.
Expression and Purification of Human
B-crystallin and
Bg--
Recombinant pET-21d(+)-H
BC and
pET-21d(+)-H
BgC expression plasmids were used to
transform competent E. coli BL21(DE3) cells (Stratagene, San
Diego, CA). Transformants were grown at 37 °C in 1 liter of Super
Broth to A600 = 0.8.
B-crystallin and
Bg expression were then induced by addition of
isopropyl-
-D-galactospyranoside to a final concentration
of 1 mM and then the culture was incubated at 37 °C for
5 h. Cells were collected by centrifugation at 3,000 × g for 10 min at 4 °C and resuspended in 25 ml of lysis
buffer, 50 mM sodium phosphate buffer, pH 7, containing 150 mM NaCl, 0.02% sodium azide, and a protease inhibitor mix
(Roche Molecular Biochemicals). Cells were disrupted by sonication on
ice. The bacterial lysates were then centrifuged at 10,000 × g for 30 min at 4 °C. The
B-crystallin and
Bg, which were primarily soluble, were purified by gel
filtration and ion exchange chromatography. The sequences of
B-crystallin and
Bg were confirmed by sequencing the
plasmids used for the expression and by mass spectral fingerprinting of
the expressed proteins. The sequences of the recombinant proteins were
identical to those of the proteins in the cataractous lenses with the
exception that the recombinant proteins were not acetylated on the N termini.
Isolation of Genomic DNA,
B-crystallin Exon 3 Amplification,
and Sequencing--
Genomic DNAs were isolated from small pieces of
lens tissue (5-10 mg) by a rapid desalting process using a DNA
purification kit (Epicentre Technologies) and following the
recommendations of the manufacturer. These DNAs (200 ng) served as
templates for PCR amplification of exon 3 and flanking regions of human
B-crystallin gene (nucleotide identifier (NID) g181075). Primers
were 24-mers in length and localized at positions 3722 (upper) and 4172 (lower). PCR cycling conditions were 40 cycles of 94 °C for 5 s, 50 °C for 30 s, and 72 °C for 1 min, using Pfu polymerase
(Promega). PCR products were sequenced by the BigDye Terminator method
(PE Applied Biosystems) using the same primers.
Chaperone-like Activity--
Chaperone-like activity was
measured as the ability to protect against the DTT-induced aggregation
of lactalbumin (30). The reaction was done at 23 °C in 50 mM sodium phosphate buffer, pH 6.9, containing 0.1 M NaCl and 2 mM EDTA. Lactalbumin was at 1 mg/ml, and crystallin was at 0.2, 0.5, and 1 mg/ml. Turbidity was
measured at 360 nm.
 |
RESULTS |
Two unique protein spots were striking on two-dimensional
electrophoresis gels of the cortical fiber cell protein from some human
cataractous lenses (Fig. 1A).
The positions of these proteins are indicated in Fig. 1A.
The spot indicated by the thick black arrow migrated at a
position one charge more acidic than
B-crystallin and at a
Mr of 22,400 which is approximately 600 less
than
B-crystallin (Fig. 1A). The second spot, indicated
by the white arrow migrated at a Mr
of 16,400. Both of these proteins reacted with antibodies made against
recombinant human
B-crystallin (Fig. 1B) suggesting that
the proteins were related to
B-crystallin. Data that will subsequently be presented in this report show that the
Mr 22,400 protein is a modified form of
B-crystallin. To simplify discussion, this protein will henceforth
be referred to as
Bg. Neither
Bg nor the
16.4-kDa protein has been observed on two-dimensional gels of total
fiber cell protein from any normal lens examined (Fig.
2 (a
c)) or in all cataracts.
The cataracts shown in Fig. 2 (d
f) that contain
Bg were not clinically classified before extraction but
were determined to be mixed cataracts by visual examination after
intracapsular extraction. The concentration of
Bg varied
from 10 to 90% of the total
B-crystallin (
Bg plus
B-crystallin) in those cataracts in which it was present. In addition, the total content of
B-crystallin (
Bg plus
B-crystallin) was significantly increased in most of these
cataracts. Representative data on three cataracts that contain high
concentrations of
Bg are shown in Table
I. Up to 5 times the normal amount of
B-crystallin was seen. This was determined by calculating the ratio
of
B-crystallin to
A-crystallin. The amount of
A-crystallin in
these cataracts was present at normal concentrations relative to
-crystallins. To our knowledge, an increase in the concentration of
B-crystallin in lenses has not been previously reported.

View larger version (36K):
[in this window]
[in a new window]
|
Fig. 1.
Two-dimensional gel electrophoresis of a
cataractous human lenses. A portion of the two-dimensional gel
protein pattern of cortical fiber cell protein was Coomassie stained
(A) and immunostained (B) with antibodies against
recombinant human B-crystallin (a gift of Dr. J. Horwitz, UCLA).
Bg, thick black arrow; typical form of B,
white arrowhead; 16.4-kDa fragment, thick white
arrow; phosphorylated Bg, thin black
arrow; and, typical form of A-crystallin, black
arrowhead.
|
|

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 2.
Composite of the
B-crystallin and
Bg from two-dimensional electrophoresis
gels of cataracts and normal human lenses. Indicated is the
position of B-crystallin and Bg. The
Coomassie-stained gels were scanned and these spots quantified to
determine the ratios of the species of B-crystallins present in
these cataracts. Normal lenses: a, 57 years; b,
17 years; and c, newborn. Cataracts with Bg:
d, e, and f, each were 60-70 years.
|
|
-Crystallins are phosphorylated in vivo; however, in the
lens the function of the phosphorylation is not known. As can be seen
in Fig. 1A (thin black arrow),
Bg
was the only form of
B-crystallin for which a phosphorylated species
was obvious; phosphorylated species of the typical form of
B-crystallin were not observed. Three phosphorylation sites have
been identified for
B-crystallin, Ser19,
Ser45, and Ser59. Mass spectral data indicated
the presence of a phosphate in the peptide corresponding to residues
2-24 in
Bg.
Characterization of
Bg--
The HPLC chromatograms
of the tryptic digests of
Bg and
B-crystallin from
cataracts of two different individuals are presented in Fig.
3. There were no consistent differences
between the chromatograms of
Bg and
B-crystallin that
were common to the respective samples from both individuals. Edman
sequencing of several tryptic peptides of
Bg was
performed. For each peptide sequenced there was 100% agreement with
the sequence of human
B-crystallin (data not shown). These results
confirm that the protein is an
B-crystallin, albeit, based on the
electrophoretic migration, a modified form of
B-crystallin. Direct
Edman sequencing of
Bg, electroblotted onto
polyvinylidene difluoride, gave no sequence, suggesting that the N
terminus of the protein was blocked. In all
Bg samples,
a peptide eluting at 40 min corresponded to the C-terminal residues
164-174. Edman sequencing verified the identity of the peptide and the
mass of the peptide agreed with its theoretical mass. The presence of C-terminal Lys175 in
Bg, however, could not
be verified by this experiment because trypsin would cleave between
Lys174 and Lys175.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 3.
HPLC chromatograms of tryptic digests of
B-crystallin and
Bg from two cataracts. Reverse
phase HPLC of native B-crystallin and Bg. Tryptic
peptides were monitored at A205.
|
|
Mass fingerprinting was done on trypsin and Asp-N protein digests of
B-crystallin and
Bg using MALDI-TOF mass
spectrometry. The results are illustrated in Tables II and III. In
Table II, the protonated molecular
weights for those peptides derived by trypsin digestion of
B-crystallin and
Bg, as well as the theoretical protonated molecular weights, are listed. The presence of peptides with
m/z values of 1430.7 and 1431.0 in the tryptic
digests of
Bg from both samples indicate that the N
terminus is present and acetylated. In the trypsin digests there were a
few masses that could not be assigned, but there were no masses
consistently present in
Bg that were missing in
B-crystallin or vice versa.
In Table III, the masses for the peptides
derived by Asp-N endoproteinase digestion are listed.
B-crystallin
samples contained peptides with m/z 3842.9 and
3842.0. These molecular weights are consistent with the C-terminal
peptide, residues 140-175, that has a theoretical
m/z value of 3842.4. A mass that corresponded to
this peptide was absent in both
Bg samples, but in both
cataracts
Bg contained a peptide absent in either
B-crystallin spot, with m/z values of 3715.0 and 3714.4 (Fig. 4). These masses are
consistent with the theoretical m/z value of the
C-terminal peptide minus Lys175, 3714.3. Asp-N
endoproteinase does not remove Lys175; therefore, the
digest product of residues 140-174 from
Bg confirms that Lys175 is not present on
Bg. In the
Asp-N digests there were very few masses that could not be assigned,
and other than the differences just discussed there were no other
peptide masses that were present in
Bg that were missing
in
B or vice versa. Only one peak corresponding to residues 129-139
(DPLTITSSLSS) was consistently absent in Asp-N spectra, and it was not
present in either crystallin. In cataract B, there was evidence for
Met68 being present as methionine sulfoxide in both
B-crystallin and
Bg. The m/z
value of 1294.9 is consistent with the expected molecular weight of
residues 62-72 plus a mass of 16 mass units. The theoretical m/z value of the same peptide with
Met68 oxidized is 1294.61. Between the two enzymatic
digestions spectra were obtained for peptides that covered 100% of the
polypeptide sequence. The regions of the polypeptide that could not be
accounted for by tryptic peptides were accounted for with the peptides
from Asp-N digests and the reverse was also true, making it possible to
detect a difference in any residue of
B-crystallin and
Bg. There were no unique modifications, amino acid
substitutions, or internal deletions detected in
Bg. The
excellent agreement of the masses obtained on the peptide digests of
Bg with the respective theoretical masses of the same
peptides in
B-crystallin indicate that there is only one difference
between
Bg and
B-crystallin. The terminal
Lys175 is missing in
Bg.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 4.
Mass spectra of C-terminal, Asp-N
endoproteinase digest peptides of native
B-crystallin and
Bg. Protein spots of
B-crystallin and Bg were cut out of a two-dimensional
gel and subjected to in-gel digestion by Asp-N endoproteinase.
Resultant peptides were extracted and analyzed by MALDI-TOF mass
spectrometry. The portions of the spectra showing the difference
between B-crystallin and Bg are shown. The
m/z value of 3842.9 corresponds to the singly
charged peptide of residues 140-175, which has a theoretical average
m/z of 3842.4. The m/z
3714.4 corresponds to the singly charged peptide of residues 140-174,
which has a theoretical average m/z of 3714.3. The absence of a peak at m/z 3842.4 and the
coincident mass at m/z 3714.4 in the spectrum of
Bg indicates that Lys175 is not present in
Bg.
|
|
The loss of the C-terminal lysine could readily explain the migration
of
Bg on two-dimensional gel electrophoresis at a
position 1 charge more acidic than the typical form of
B-crystallin.
However, it did not seem likely that the loss of one lysine (128 mass
units) could explain the migration of
Bg at the lower
molecular weight. The only reasonable explanations were that
Bg had region(s) of structure different from
B-crystallin that remained throughout the electrophoresis even in
the presence of 9 M urea, 2% Nonidet P-40 or 1% SDS and
affected its electrophoretic migration, or that an adduct was lost
during the subsequent analyses.
Recombinant Human
B-crystallin and
Bg--
To
test whether the removal of the C-terminal lysine was sufficient to
induce the altered migration on electrophoresis as was observed in the
second dimension of two-dimensional electrophoresis, both human
B-crystallin and human
B-crystallin minus the C-terminal lysine
(
Bg) were cloned and expressed in E. coli.
Both were expressed as soluble proteins in this system. Neither protein
was acetylated on the N-terminal methionine. The recombinant human
B-crystallin and the recombinant human
Bg eluted from
a Superose 6 gel filtration column as aggregates with apparent
molecular weights of 570,000 and 510,000, respectively (Fig.
5). Significantly smaller species were
also observed for
Bg (data not shown). As shown in Fig. 6A, even after boiling in SDS,
the recombinant
Bg migrated slightly faster than
recombinant
B-crystallin on SDS-PAGE. The calculated difference in
the molecular weight between the recombinant
B-crystallin and
recombinant
Bg was approximately 700, similar to the
difference observed on two-dimensional gels of lens proteins. These
results show that the removal of the C-terminal lysine is sufficient to cause the migration of
Bg at a significantly lower
molecular weight than
B-crystallin. The pI values determined by
isoelectric focusing under non-denaturing conditions for both proteins
are shown in Fig. 6B. The recombinant
B-crystallin had a
native pI of 6.8, and recombinant
Bg had a native pI of
5.8. The theoretical pI values are 6.76 and 6.50, respectively.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 5.
Oligomeric sizes of recombinant human
B crystallin and
Bg. Recombinant human
B-crystallin and Bg were purified by gel filtration
and ion exchange chromatography. The figure is an overlay of the final
purification chromatograms of both recombinant proteins from a Superose
6 HR 10/30 gel filtration column. Recombinant human B-crystallin
peak (solid line) eluted at ~570 kDa (90% of the peak
area was in the range of 270-970 kDa) and recombinant human
Bg peak (dotted line) eluted at ~510 kDa
(90% of the peak area was in the range of 260-940 kDa). The column
was calibrated immediately before purification of both recombinants
using thyroglobulin (669 kDa), -amylase (200 kDa), bovine serum
albumin (66 kDa), and carbonic anhydrase (30 kDa)
(inset).
|
|

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 6.
SDS-PAGE and native isoelectric
focusing of recombinant human
B-crystallin and
Bg. The relative sizes of the
subunits of purified rh B-crystallin and rh Bg were
calculated from their migration on 14% polyacrylamide gels. The
relative isoelectric points of the two recombinants were calculated
from their migration under native conditions on 5% polyacrylamide
isoelectric focusing gel. SDS-PAGE: lanes 1 and
6, molecular weight markers; lanes 2 and
3, rh B-crystallin (21.5 kDa); lanes 4 and
5, rh Bg (20.7 kDa). Native isoelectric
focusing: lanes 1 and 6, isoelectric point
markers; lanes 2 and 3, rh B-crystallin (pI
6.8); lanes 4 and 5, rh Bg (pI
5.8).
|
|
Chaperone-like Activity--
-Crystallins exhibit a
chaperone-like activity, protecting against aggregation of proteins
that is induced by heat, oxidation, and reduction by DTT (30). The
effect of the removal of the C-terminal lysine on the chaperone-like
activity of
B-crystallin was assessed by determining the ability of
the recombinant forms of human
B-crystallin and
Bg to
prevent the DTT-induced aggregation of lactalbumin. As shown in Fig.
7, the removal of the C-terminal lysine
had essentially no effect on the chaperone-like activity of this
protein under these conditions.

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 7.
Chaperone-like activity of recombinant
human B-crystallin and
Bg. The incubation mixture
contained 50 mM sodium phosphate, 0.1 M NaCl, 2 mM EDTA, pH 6.9, 50 mM DTT, and 1 mg/ml
-lactalbumin, in the absence ( ) and presence of
rh B-crystallin, 1 mg/ml ( ), 0.5 mg/ml ( ), and 0.2 mg/ml (+)
(A); 1 mg/ml -lactalbumin in the absence ( ) and
presence of rh Bg 1 mg/ml ( ), 0.5 mg/ml ( ), and 0.2 mg/ml (×) (B).
|
|
16.4-kDa Protein--
The 16.4-kDa protein was present at a
concentration about one-tenth that of
Bg and has only
been observed in samples that contain
Bg. Direct Edman
sequencing was performed on the 16.4-kDa protein from cataracts of two
different individuals. These data are shown in Fig.
8. The 16.4-kDa protein in lens 1 yielded
multiple N-terminal sequences, Ser43, Ser41,
Ser45, and Phe47. All sequences were identical
to
B-crystallin. MALDI-TOF derived data on the 16.4-kDa protein from
a third individual indicated the N termini were Ser43 and
Ser41. In a fourth individual the N terminus was
Pro39 (Table IV). Two of the
cleavages were between Thr and Ser, one between Leu and Ser, one
between Pro and Phe, and the fourth was between Phe and Pro. The
significance of these data is that multiple N termini have been
identified, each different by two or multiples of two residues.

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 8.
N-terminal sequences of
B-crystallin 16-kDa fragments. N-terminal
sequences of the 16.4 kDa are compared with the B-crystallin
sequence. Sequencing was performed by Harvard MicroChem.
Underlined residues are lower confidence. For lens 1, determination of the predominance of sequences was done by Harvard
Microchem using the relative concentrations of amino acids in each
cycle and the typical yields of each amino acid.
|
|
Tryptic digests of this spot were similar but not identical to that of
B-crystallin. A peptide with a mass of 1140 Da that eluted at the
same time as a peptide identified by sequencing as residues 164-174
was present. MALDI-TOF mass spectral analysis of Asp-N endoproteinase
digests showed the absence of a peak at m/z
3842.4 which would correspond to residues 140-175 of
B-crystallin (Table IV). There was, however, a peak at m/z
3714.5 which corresponds to residues 140-174. As shown in Table IV,
experimental m/z values were matched to
theoretical m/z values from Asp-N cleavage that covered most of the polypeptide. Aside from the N-terminal peptides, the only mass missing was the same one not observed in
B and
Bg. A unique peak at m/z 3130.5 was observed. This mass may correspond to residues 39-66 (3129.8).
These results show that the 16.4-kDa protein is derived from
Bg.
Genomic Analysis--
The mechanism by which
Bg is
generated in these cataractous lenses is not known. One possibility was
that
Bg is the product of a mutated gene for
B-crystallin since a single nucleotide change could convert the
codon for lysine to a stop codon. To test this possibility PCR products
were obtained for the last exon of the
B-crystallin gene using
genomic DNA prepared from lenses containing
Bg. The
sequences of the PCR products indicated that there was no mutation in
the gene for
B-crystallin (data not shown).
 |
DISCUSSION |
We have demonstrated that in some human cataracts the
concentration of the small heat shock protein,
B-crystallin, is
significantly increased. This could be the result of an up-regulation
of its expression and/or a diminution of its degradation in the lens. Regardless, it represents a significant deviation from the normal protein composition of the lens and is the first time such an observation has been made in a human cataract. We have also provided evidence for aberrant N- and C-terminal processing of
B-crystallin. One atypical form of
B-crystallin found in high concentrations in
these cataracts has been designated
Bg. This species is
B-crystallin minus the C-terminal lysine. A second atypical form of
B-crystallin, found at about 10% the concentration of
Bg, is a 16.4-kDa fragment of
Bg. In this
protein 38-46 N-terminal residues have also been removed.
The removal of the C-terminal lysine does not diminish the
chaperone-like activity of
B-crystallin under the conditions used for these studies. As reported here (Fig. 7) the chaperone-like activity of the recombinant human
Bg is comparable to
that of the recombinant human
B-crystallin in protecting against the DTT-induced aggregation of lactalbumin at room temperature.
A- and
B-crystallin have polar, flexible C-terminal extensions that are
thought to contribute to the solubility of these crystallins and have
been implicated in their chaperone-like activity (31). Substitution of
Lys174-Lys175 of
B-crystallin with Leu-Leu
significantly diminished chaperone-like activity; however, removal of
the last 5 residues had little effect on chaperone-like activity (32).
Likewise, in
A-crystallin the introduction of tryptophan at the C
terminus and removal of 17 C-terminal residues diminished
chaperone activity (33-35). Maintenance of a polar, flexible
C-terminal extension appears to be an important factor for maintaining
chaperone-like activity (33). Thus, it is not surprising that
Bg has full activity in protecting against the
DTT-induced aggregation of lactalbumin.
The only modification identified for
Bg was the loss of
Lys175. There was nothing in the mass spectral, HPLC, and
protein sequence data that suggested an additional modification. The N
and C termini of the protein were otherwise intact. The N-terminal
methionine was acetylated, and every peptide sequence examined matched
B-crystallin exactly. With the exception of the mass corresponding
to the loss of the C-terminal lysine, there were no masses found by
MALDI-TOF mass spectrometry that were consistently present in
Bg that were not present in
B-crystallin from the
same cataract and vice versa. This held for both Asp-N and
trypsin digests of the proteins, and, combining data from both digests,
the entire sequences of both
Bg and
B-crystallin were
analyzed. These data rule out splice variants and other mutations
unless replacements have the same mass and would not be detected in the
MALDI-TOF mass spectrometry fingerprint analysis.
It was confirmed that the removal of the carboxyl-terminal lysine
(128.09 mass units) was responsible for the faster migration of
Bg on SDS-PAGE relative to
B-crystallin. This was
demonstrated using the recombinant forms of these proteins. In addition
to showing that a difference of one lysine was sufficient to alter the
migration on SDS-PAGE, it also supported the conclusion that the only
modification of
Bg was the lack of the terminal lysine. Smulders et al. (33) demonstrated that a mutant of
A-crystallin with an extension of ALRKG migrated on SDS-PAGE
slightly slower than mutants with ALGKG or ALDKG. Thus, addition of one
more positive charge in the C-terminal extension of either
A- or
B-crystallin can slightly retard its electrophoretic mobility.
In this study,
Bg and the 16.4-kDa proteins were only
observed in cataracts but not in all human cataracts. Over 70 cataracts from 60 to 90 years have been analyzed. Eight cataracts have the high
concentration of
Bg. Many other cataracts have
Bg but at lower concentrations. So far, a correlation
cannot be made between the presence of these proteins in cataracts and
any cataract etiology. Neither
Bg nor the 16.4-kDa
fragment have been observed in our laboratory on two-dimensional
electrophoresis of normal human lens total protein, water-soluble or
water-insoluble fractions, of about 50 non-cataractous lenses (newborn
to 75 years). However, the presence in a normal lenses of a low
concentration of an
-crystallin with a mass that corresponded to
B-crystallin minus the C-terminal lysine has been reported using
liquid chromatography/mass spectrometry (36-38). The sensitivity of
electrospray ionization mass spectrometry made the detection of very
low levels of
Bg in non-cataractous lenses possible,
whereas Fig. 2 clearly shows that
Bg is not detected by
Coomassie Blue staining of normal lens proteins. The findings in other
laboratories suggest that at least very low concentrations of
Bg may exist in normal lenses and that
Bg and possibly the 16.4-kDa fragment may be intermediates in the normal
pathway of processing
B-crystallin (36-38). In the cataracts examined in this study, there may be increases and/or decreases in
proteinases that result in the accumulation of these species. Interestingly,
A-crystallin which has Ser-Ser as the final
C-terminal residues is found with only the final Ser removed (60). This form of
A-crystallin has been observed in normal human and bovine lenses. The functional significance of the modified form is not known.
Furthermore, the significance of the processing of
-crystallins to
cataractogenesis is not known.
Multiple proteinases are certain to be involved in the
post-translational modification of
B-crystallin generating
Bg and the 16.4-kDa fragment. The data reported in this
study rule out the possibility that
Bg is the result of
a mutation in the
B-crystallin gene but cannot rule out a genetic
component involving other genes such as proteinases or involving the
regulation of proteinases. There was a high incidence of
Bg in cataracts from India. This supports the
possibility of a genetic component. Alternatively, the high incidence
in cataracts from India could indicate the presence of a particular
form of stress on the lens which alters the proteinase activities.
In
Bg the terminal lysine is removed but not the
penultimate lysine. The first cleavage would be a Lys-Lys cleavage and
the second a Pro-Lys cleavage. Carboxypeptidases have been described that are specific for basic amino acids for which the penultimate amino
acid alters the rate of cleavage (39). Peptide carboxypeptidases have
been described that will not cleave prolysyl bonds, and endopeptidases with specificity for pairs of basic amino acids that will remove one or
both of the basic residues have been described (39). Thus, the
specificity for removing one but not both lysine residues is possible;
however, whether any of these proteinases are in the lens is not known.
If the removal of the C-terminal lysine is related to function, it is
possible a specific carboxypeptidase may be induced during stress.
The 16.4-kDa protein is an N-terminally truncated form of
Bg and was only observed in those lenses in which
Bg was in high concentration. Multiple N termini were
identified, but the major N terminus was Ser43. Since each
N terminus represented the removal of two residues or multiples of two,
it is reasonable to suggest that cleavage is catalyzed by a dipeptidyl
peptidase. Dipeptidyl peptidases II (lysosomal) and III (cytoplasmic)
are present in lens and cataracts (40, 41). However, both of these
preferentially use peptides as substrates, not proteins. Dipeptidyl
peptidases that utilize proteins as substrates exist but, to our
knowledge, have not been described in the lens. The N termini of
Bg and
B-crystallin are blocked, so presumably a
different proteinase made the first cleavage. Acylaminohydrolases that
could cleave the acetylmethionine are present in lenses (42).
Our hypothesis is that a stress mechanism is involved in generating
both the high concentrations of
B-crystallin and the subsequently
modified forms,
Bg and the 16.4-kDa protein, and that
the increased concentration of
B-crystallin is an effort by the lens
to protect against loss of lens function. That a stress mechanism is
involved is strongly supported by our observation that
Bg was present in the lens from an infant with
microphthalmia, coloboma, and persistent hyperplastic primary
vitreous.2 The latter is a
condition where the vessels do not regress at the appropriate time in
development and cells invade the back of the lens. Our assumption is
that this is perceived by the lens as an extreme stress condition. In
addition, two forms of
B-crystallin were induced in hypertonically
stressed dog lens epithelial cells in culture (21). Direct evidence is
not yet available, but it is highly likely, based on the migration on
two-dimensional gels, that the atypical form of
B-crystallin found
is
Bg.
B-crystallin is a member of the family of
small heat shock proteins and in cultured cells, including lens cells,
B-crystallin is induced by heat shock, oxidative stress, osmotic
stress, sodium arsenite, phorbol 12-myristate 13-acetate, and hormones
such as estrogen and dexamethasone (20-23, 43, 44). Heat shock
proteins are also phosphorylated in response to stress (45).
-Crystallins are phosphorylated in vivo and in
vitro (46-48). The role of phosphorylation of
B-crystallin in
lens is not understood, but
Bg was preferentially phosphorylated in the cataracts examined.
This is the first time an increased concentration of
B-crystallin
has been described in vivo in human lenses. The increased concentration is due to the presence of
Bg not to an
increased concentration of the typical form of
B-crystallin. Due to
the nature of the lenses, it is difficult to determine whether there is
truly an increased expression or a decreased degradation of
B-crystallin. If the increased concentration of
B-crystallin reflects diminished processing, the degradation of this protein must
occur at a much greater rate in human lens than previously appreciated.
We propose that there is an increased expression due to chronic stress
conditions and altered processing of
B-crystallin generating
Bg in these cataracts.
B-crystallin also accumulates in brains of individuals with neurological disorders (49-51). It is
unclear in these cases, as well as the cataracts, whether the presence
of
B-crystallin is an attempt to rescue the tissue or if it is a
contributor to the pathology. We think it is unlikely that the
increased concentration of
B-crystallin and the presence of the
modified forms cause the loss of lens clarity in the cataracts, but it
must be considered.
The functional significance of the post-translational modification of
B-crystallin described here is not known. In the intact lens, it is
unclear whether the primary function of
B-crystallin is that of a
stress protein and related to its chaperone-like activity or if it is
structural. The findings that
Bg is present in a lens
with persistent hyperplastic primary vitreous and is induced by
hypertonic stress in lens cells suggests a major role is
stress-related. Based on a number of reports,
B-crystallin interacts
with actin, intermediate filaments, membranes, and components in cell
nuclei (52-57). Lys175 has been implicated as an amine
donor substrate for transglutaminase reactions (58, 59). The data
presented suggest
Bg has some difference in structure
from the typical form of
B-crystallin. This is likely to alter
specific protein-protein interactions. In fact, the larger than
expected change in the native pI of
Bg supports the
observations that the C-terminal lysine is involved in intramolecular
interactions and is likely to affect intermolecular interactions
as well. Further evidence for this is the preferential phosphorylation
of
Bg over
B-crystallin.
Studies in progress will hopefully elucidate the mechanisms involved in
the increased concentration of
B-crystallin and the function of
Bg in lens and in cataracts. They will also determine whether the pathway for modification of
B-crystallin is one specific to lens or is a general pathway induced by stress in other tissues.
 |
ACKNOWLEDGEMENTS |
We are very grateful to the tissue and organ
donors and their families for their contribution to this study.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Both authors contributed equally to this work.

Present address: Ophthalmology Dept., University of Modena,
Modena, Italy.
§§
To whom correspondence should be addressed: Laboratory of
Mechanisms of Ocular Diseases, NEI, Bldg. 6, Rm. 235, National
Institutes of Health, Bethesda, MD 20892. Tel.: 301-496-6999; Fax:
301-496-1759; E-mail: dgarland@helix.nih.gov.
2
D. Garland, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
DTT, dithiothreitol;
PCR, polymerase chain reaction;
MALDI-TOF, matrix-assisted laser
desorption ionization-time of flight;
PAGE, polyacrylamide gel
electrophoresis;
HPLC, high pressure liquid chromatography.
 |
REFERENCES |
| 1.
|
Hoenders, H. J.,
and Bloemendal, H.
(1983)
J. Gerontol.
38,
278-286[Medline]
[Order article via Infotrieve]
|
| 2.
|
Bloemendal, H.
(ed)
(1981)
Molecular and Cellular Biology of the Eye Lens
, pp. 279-405, John Wiley & Sons, Inc., New York
|
| 3.
|
Harding, J. J.,
and Dilley, K. J.
(1976)
Exp. Eye Res.
22,
1-73[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Groenen, P. J.,
Merck, K. B.,
de Jong, W. W.,
and Bloemendal, H.
(1994)
Eur. J. Biochem.
225,
1-19[Medline]
[Order article via Infotrieve]
|
| 5.
|
Dubin, R. A.,
Wawrousek, E. F.,
and Piatigorsky, J.
(1989)
Mol. Cell. Biol.
9,
1083-1091[Abstract/Free Full Text]
|
| 6.
|
Bhat, S. P.,
and Nagineni, C. N.
(1989)
Biochem. Biophys. Res. Commun.
158,
319-325[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Srinivasan, A. N.,
Nagineni, C. N.,
and Bhat, S. P.
(1992)
J. Biol. Chem.
267,
23337-23341[Abstract/Free Full Text]
|
| 8.
|
Bindels, J. G.,
Bessems, G. J.,
de Man, B. M.,
and Hoenders, H. J.
(1983)
Comp. Biochem. Physiol. B
76,
47-55[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Augusteyn, R. C.
(1998)
Exp. Eye Res.
66,
669-674[CrossRef][Medline]
[Order article via Infotrieve]
|
| 10.
|
Ingolia, T. D.,
and Craig, E. A.
(1982)
Proc. Natl. Acad. Sci. U. S. A.
79,
2360-2364[Abstract/Free Full Text]
|
| 11.
|
Klemenz, R.,
Andres, A. C.,
Frohli, E.,
Schafer, R.,
and Aoyama, A.
(1993)
J. Cell Biol.
120,
639-645[Abstract/Free Full Text]
|
| 12.
|
de Jong, W. W.,
Hendriks, W.,
Mulders, J. W.,
and Bloemendal, H.
(1989)
Trends Biochem. Sci.
14,
365-368[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Wistow, G.
(1985)
FEBS Lett.
181,
1-6[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Merck, K. B.,
Groenen, P. J.,
Voorter, C. E.,
de Haard-Hoekman, W. A.,
Horwitz, J.,
Bloemendal, H.,
and de Jong, W. W.
(1993)
J. Biol. Chem.
268,
1046-1052[Abstract/Free Full Text]
|
| 15.
|
Horwitz, J.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
10449-10453[Abstract/Free Full Text]
|
| 16.
|
Jakob, U.,
Gaestel, M.,
Engel, K.,
and Buchner, J.
(1993)
J. Biol. Chem.
268,
1517-1520[Abstract/Free Full Text]
|
| 17.
|
de Jong, W. W.,
Mulders, J. W.,
Voorter, C. E.,
Berbers, G. A.,
Hoekman, W. A.,
and Bloemendal, H.
(1988)
Adv. Exp. Med. Biol.
231,
95-108[Medline]
[Order article via Infotrieve]
|
| 18.
|
Smith, J. B.,
Sun, Y.,
Smith, D. L.,
and Green, B.
(1992)
Protein Sci.
1,
601-608[Abstract]
|
| 19.
|
Chiesa, R.,
Gawinowicz-Kolks, M. A.,
Kleiman, N. J.,
and Spector, A.
(1987)
Biochem. Biophys. Res. Commun.
144,
1340-1347 |